528 related articles for article (PubMed ID: 16119190)
1. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
[TBL] [Abstract][Full Text] [Related]
9. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT
Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000
[TBL] [Abstract][Full Text] [Related]
10. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
Ozensoy O; Puccetti L; Fasolis G; Arslan O; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Nov; 15(21):4862-6. PubMed ID: 16168653
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
16. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
Knaus EE; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
[TBL] [Abstract][Full Text] [Related]
17. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII.
Alafeefy AM; Isik S; Abdel-Aziz HA; Ashour AE; Vullo D; Al-Jaber NA; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1396-403. PubMed ID: 23290254
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Sep; 45(9):3656-61. PubMed ID: 20554082
[TBL] [Abstract][Full Text] [Related]
20. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
Guler OO; De Simone G; Supuran CT
Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
